老年组以淋巴肉瘤细胞白血病为主，非老年组以急淋l_1和L_2型为主。
Most of ALL in elderly was lymphosarcoma cell leukemia, but ALL-L1 and L2 in non-elderly.
目的：为提高急性非淋巴细胞性白血病(急非淋)的疗效。
Objective To improve the therapeutic effect of acute non-lymphatic leukemia (ANLL).
目的：为提高急性非淋巴细胞性白血病(急非淋)的疗效。
Objective To improve the therapeutic effect of acute non-lymphatic leukemia (ANLL).
应用推荐